Lesions
| . | No. of lesions . | ||
|---|---|---|---|
| . | Stable . | Unstable . | Total . |
| Ad.empty | 8 | 2 | 10 |
| Ad.hVEGF-A | 3 | 8 | 11 |
| Total | 11 | 10 | 21 |
| . | No. of lesions . | ||
|---|---|---|---|
| . | Stable . | Unstable . | Total . |
| Ad.empty | 8 | 2 | 10 |
| Ad.hVEGF-A | 3 | 8 | 11 |
| Total | 11 | 10 | 21 |
Lesions were categorized according to their morphologic features for stability (by 2 blinded observers). Fibrous lesions and atheromatous plaques were considered stable, whereas thin-capped plaques and plaques with adverse events (eg, intraplaque hemorrhage, cap break, or intramural thrombi) were considered unstable. VEGF-A overexpression led to a higher prevalence of unstable plaques (P = .03).